Characteristics | RRM1 | RRM2B | 2R | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Normal | Aberrant | Normal | Aberrant | Normal | Aberrant | ||||||||||
No. | (%) | No. | (%) | Pa | No. | (%) | No. | (%) | Pa | No. | (%) | No. | (%) | Pa | |
No. of patients | 211 | 40 | 217 | 34 | 184 | 67 | |||||||||
PAM50 b | 0.38 | 0.0004 | 0.009 | ||||||||||||
Luminal A | 63 | (29.9) | 8 | (20.0) | 70 | (32.3) | 1 | (2.9) | 62 | (33.7) | 9 | (13.4) | |||
Luminal B | 74 | (35.1) | 15 | (37.5) | 75 | (34.6) | 14 | (41.2) | 62 | (33.7) | 27 | (40.3) | |||
Basal-like | 32 | (15.2) | 10 | (25.0) | 35 | (16.1) | 7 | (20.6) | 27 | (14.7) | 15 | (22.4) | |||
HER2-enriched | 37 | (17.5) | 7 | (17.5) | 33 | (15.2) | 11 | (32.4) | 29 | (15.8) | 15 | (22.4) | |||
Unknown | 5 | (0.0) | 0 | (0.0) | 4 | (1.8) | 1 | (2.9) | 4 | (2.2) | 1 | (1.5) |